432 related articles for article (PubMed ID: 27197918)
21. Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group.
Mayo SJ; Lustberg M; M Dhillon H; Nakamura ZM; Allen DH; Von Ah D; C Janelsins M; Chan A; Olson K; Tan CJ; Toh YL; Oh J; Grech L; Cheung YT; Subbiah IM; Petranovic D; D'Olimpio J; Gobbo M; Koeppen S; Loprinzi CL; Pang L; Shinde S; Ntukidem O; Peters KB
Support Care Cancer; 2021 Jun; 29(6):2821-2840. PubMed ID: 33231809
[TBL] [Abstract][Full Text] [Related]
22. Cognitive Changes Related to Cancer Therapy.
Vannorsdall TD
Med Clin North Am; 2017 Nov; 101(6):1115-1134. PubMed ID: 28992858
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer plus adjuvant chemotherapy- related cognitive impairment: a case study.
Fischer B
Neurocase; 2019; 25(3-4):138-144. PubMed ID: 31237172
[TBL] [Abstract][Full Text] [Related]
24. Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy.
Cerulla Torrente N; Navarro Pastor JB; de la Osa Chaparro N
J Cancer Surviv; 2020 Aug; 14(4):464-482. PubMed ID: 32146576
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and associated factors of chemotherapy-related cognitive impairment in older breast cancer survivors.
Zhou X; Zhang X; Zhong T; Zhou M; Gao L; Chen L
J Adv Nurs; 2024 Feb; 80(2):484-499. PubMed ID: 37675947
[TBL] [Abstract][Full Text] [Related]
26. Predictors of baseline cancer-related cognitive impairment in cancer patients scheduled for a curative treatment.
Lycke M; Pottel L; Pottel H; Ketelaars L; Stellamans K; Van Eygen K; Vergauwe P; Werbrouck P; Goethals L; Schofield P; Boterberg T; Debruyne PR
Psychooncology; 2017 May; 26(5):632-639. PubMed ID: 27338029
[TBL] [Abstract][Full Text] [Related]
27. Advances of neuroimaging in chemotherapy related cognitive impairment (CRCI) of patients with breast cancer.
Yao S; Zhang Q; Yao X; Zhang X; Pang L; Yu S; Cheng H
Breast Cancer Res Treat; 2023 Aug; 201(1):15-26. PubMed ID: 37329458
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats.
Lomeli N; Di K; Czerniawski J; Guzowski JF; Bota DA
Free Radic Biol Med; 2017 Jan; 102():274-286. PubMed ID: 27908784
[TBL] [Abstract][Full Text] [Related]
29. Self-reported cognitive outcomes among adolescent and young adult patients with noncentral nervous system cancers.
Tan CJ; Mah JJJ; Goh WL; Poon E; Harunal Rashid MF; Chan A
Psychooncology; 2020 Aug; 29(8):1355-1362. PubMed ID: 32597001
[TBL] [Abstract][Full Text] [Related]
30. Cancer-related cognitive impairment is associated with perturbations in inflammatory pathways.
Oppegaard K; Harris CS; Shin J; Paul SM; Cooper BA; Chan A; Anguera JA; Levine J; Conley Y; Hammer M; Miaskowski CA; Chan RJ; Kober KM
Cytokine; 2021 Dec; 148():155653. PubMed ID: 34388477
[TBL] [Abstract][Full Text] [Related]
31. Predictors of cognitive impairment in patients undergoing ileostomy for colorectal cancer: a retrospective analysis.
Xu J; Yang Y; Hu D
PeerJ; 2023; 11():e15405. PubMed ID: 37304889
[TBL] [Abstract][Full Text] [Related]
32. Young Adults' Lived Experiences with Cancer-Related Cognitive Impairment: An Exploratory Qualitative Study.
Sharma S; Brunet J
Curr Oncol; 2023 Jun; 30(6):5593-5614. PubMed ID: 37366905
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and assessment tools of cancer-related cognitive impairment in lung cancer survivors: a systematic review and proportional meta-analysis.
Ho MH; So TW; Fan CL; Chung YT; Lin CC
Support Care Cancer; 2024 Mar; 32(4):209. PubMed ID: 38441715
[TBL] [Abstract][Full Text] [Related]
34. Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions.
Onzi GR; D'Agustini N; Garcia SC; Guterres SS; Pohlmann PR; Rosa DD; Pohlmann AR
Drug Saf; 2022 Jun; 45(6):601-621. PubMed ID: 35606623
[TBL] [Abstract][Full Text] [Related]
35. Measurement, outcomes and interventions of cognitive function after breast cancer treatment: A narrative review.
Jia M; Zhang X; Wei L; Gao J
Asia Pac J Clin Oncol; 2021 Aug; 17(4):321-329. PubMed ID: 33079484
[TBL] [Abstract][Full Text] [Related]
36. Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx.
Wagner LI; Gray RJ; Sparano JA; Whelan TJ; Garcia SF; Yanez B; Tevaarwerk AJ; Carlos RC; Albain KS; Olson JA; Goetz MP; Pritchard KI; Hayes DF; Geyer CE; Dees EC; McCaskill-Stevens WJ; Minasian LM; Sledge GW; Cella D
J Clin Oncol; 2020 Jun; 38(17):1875-1886. PubMed ID: 32271671
[TBL] [Abstract][Full Text] [Related]
37. Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study.
Duivon M; Lequesne J; Di Meglio A; Pradon C; Vaz-Luis I; Martin AL; Everhard S; Broutin S; Rigal O; Bousrih C; Lévy C; Lerebours F; Lange M; Joly F
Breast Cancer Res; 2024 Jun; 26(1):93. PubMed ID: 38840166
[TBL] [Abstract][Full Text] [Related]
38. Australian oncology health professionals' knowledge, perceptions, and clinical practice related to cancer-related cognitive impairment and utility of a factsheet.
He S; Lim CYS; Dhillon HM; Shaw J
Support Care Cancer; 2022 Jun; 30(6):4729-4738. PubMed ID: 35122530
[TBL] [Abstract][Full Text] [Related]
39. Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial.
Juan Z; Chen J; Ding B; Yongping L; Liu K; Wang L; Le Y; Liao Q; Shi J; Huang J; Wu Y; Ma D; Ouyang W; Tong J
Eur J Cancer; 2022 Jan; 161():10-22. PubMed ID: 34896904
[TBL] [Abstract][Full Text] [Related]
40. Self-reported chemotherapy-related cognitive impairment compared with cognitive complaints following menopause.
Vega JN; Dumas J; Newhouse PA
Psychooncology; 2018 Sep; 27(9):2198-2205. PubMed ID: 29904964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
